secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-RAD LABORATORIES, INC. (BIO)
CIK:        0000012208
Form:       8-K
Filed at:   2024-09-09T23:59:59+00:00
Accession:  0000012208-24-000056
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Rad amends bylaws to update stockholder meeting procedures and proxy rules
------------------------------------------------------------------------------

- Board amended Bylaws effective Sept 6, 2024, adding electronic stockholder meeting participation and universal proxy rule compliance.
- Eliminated requirement to make stockholder list available at meetings.
- Clarified CEO role as separate from President; required proxy solicitors to use non-white proxy card color.
- Updated procedures for director nominations and other business proposals, including Rule 14a-19 universal proxy rules.
- Made other administrative, clarifying, and conforming changes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/12208/000001220824000056/0000012208-24-000056-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/12208/000001220824000056/bio-20240906.htm
  HTML page:      https://secwatch.observer/filing/0000012208-24-000056

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer